Gill Livingston, MBChB, MD, FRCPsych

Reader in the psychiatry of older people at the Department of Mental Health Science as well as Consultant Psychiatrist at the Camden and Islington Mental Health and Social Care Trust. Senior Clinical Advisor for the North Thames Dementias and Neurodegenerative Diseases Research Network (DeNDRoN).                                               

Email: g.livingston@ucl.ac.uk

Professor Livingston has recently been involved in a series of epidemiological studies on older people with dementia and their caregivers. Currently, her research interests include mental illness of older people in the community, particularly in relation to dementia and caregivers, elder abuse and dementia, and dementia in minorities. Her main projects are a longitudinal study of an epidemiologically representative cohort of people with Alzheimer’s disease (the LASER-AD study), a study of dementia and its subtypes in people with learning disability (the BOLD-memory project), a study of the link between carer psychological ill health and abuse, and dementia prevalence in African-Caribbeans.

Declaration of interest: None

Cornelius Katona, MD FRCPsych

Dean of the Kent Institute of Medicine and Health Sciences, University of Kent. Foundation Professor of Psychiatry of the Elderly at University College London. Co-chair of the World Psychiatric Association sections of affective disorders and of old age, and co-founder and Vice-President of the International Society for Affective Disorders.   

Email: c.katona@ucl.ac.uk

Between 1998 and 2003, Professor Katona served as Dean of the Royal College of Psychiatrists. His research interests include medical education, affective disorders in old age, the epidemiology and health economics of psychiatric disorders in old age, and imaging in dementia. Appointed Editor-in-Chief of the Journal of Affective Disorders in 1994, he is the author of over 150 peer-reviewed articles and author/editor of 15 books.

Declaration of interest: Cornelius Katona has received grant funding, given paid lectures and provided consultancy for pharmaceutical companies involved in dementia treatments.